Abstract - European Medical Journal

Continue

Abstracts

Oncology
2 Mins
29th October 2024

Predisposition, Clinical Characteristics and Management of Immune Checkpoint Inhibitor-Induced Nephritis

Immune checkpoint inhibitors (ICI) use can lead to an array of immune-related adverse events (irAE). Nephritis is considered to be…
Oncology
5 Mins
29th October 2024

ESMO 2024 Abstract Highlights

The following abstracts showcase the top cutting-edge research presented at the European Society for Medical Oncology (ESMO) Congress 2024…
Diabetes
1 Mins
25th October 2024

Meal Timing: its Relation to Metabolism and Heritability

Meal timing is a crucial factor influencing metabolic health, which can be explained by the tight interaction between circadian clocks and…
Diabetes
1 Mins
25th October 2024

Screening and Monitoring for Presymptomatic Type 1 Diabetes

Type 1 diabetes (T1D), coeliac disease (CD), and autoimmune thyroid disease (AITD), abbreviated as TRIAD diseases, are three common…
Diabetes
1 Mins
25th October 2024

Sex-Specific Differences of Human Skeletal Muscle

Exercise is a potent skeletal muscle stimulus and the most effective strategy to prevent weight loss-related muscle loss and Type 2…
Diabetes
8 Mins
25th October 2024

EASD 2024 Abstract Highlights

NEW RESEARCH presented at EASD 2024 revealed that maternal Type 1 diabetes (T1D) provides long-term relative protection against the…
Respiratory
2 Mins
22nd October 2024

Antifibrotic Treatment Efficacy in Progressive Pulmonary Fibrosis

In cases of pulmonary fibrosis attributable to interstitial lung disease, whether the aetiology is known or unknown, the presence…
Respiratory
1 Mins
22nd October 2024

Phase IIb Study Design of Inhaled Pirfenidone for Progressive Pulmonary Fibrosis Treatment

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of pulmonary…